‘Full Speed Ahead’ with Test Results? Not So Fast
Lab scientists using testing equipment too quickly brings up training concerns in discussions at recent ADLM conference
Inside the Diagnostics Industry-dtet
A 21st Century Response to the Cures Act
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
Expert Q&A: What’s Next in Next-Generation Sequencing?
Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.
Diagnostic danger in the lab: Time to reform how we process orders
Recent report examining 10,000 claims to understand the key drivers of medical malpractice suits found 52 percent involved lab-related errors.
Tests Emerging to Advance Cardiovascular Risk Assessment
From - Diagnostic Testing & Emerging Technologies
While testing for cardiovascular conditions does not garner the headlines that oncology testing does, several recent studies demonstrate how the introduction of genetic testing and…
Outreach Survey Focuses on Clinical Laboratory Industry Trends Amidst Greatest Disruption in Three Decades
By Jeff Myers bio
Accumen Inc. is pleased to announce the launch of the 17th Annual National Hospital and Health System Laboratory and Outreach Survey. The survey is designed to capture intelligence on…
FDA’s Two Big Moves on NGS-Based Tumor Panels May Offer Clues for Alternative Pathways for LDT Approval
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Inside the Diagnostics Industry: Laboratory Data Core to Value-Based Health Care
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Diagnostics Industry Responding to Opioid Epidemic
From - Diagnostic Testing & Emerging Technologies
Prescription opioids are among the most common drugs prescribed and are the most effective treating for pain, whether it is debilitating, chronic pain or…
Curetis to Launch Multiplex MDx for Hospital Infections in U.S.
From - Diagnostic Testing & Emerging Technologies
Molecular diagnostics firm Curetis (Germany) specializes in solutions to rapidly diagnose and profile antibiotic resistance for severe infections in hospitalized…
Testing Guidelines at a Glance
From - Diagnostic Testing & Emerging Technologies
The American Society of Clinical Oncology (ASCO) published updated practice guidelines Aug. 14 in the Journal of Clinical Oncology regarding the use of…
Inside the Diagnostics Industry: At-Home Testing Options Expanding
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Genomic Testing May Be Currently Overhyped, Oncologists Say
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here